recently identified a distinct immune-regulatory population of (CD14+HLA-DR+) AXL-expressing monocytes that is expanded in parallel with progression of cirrhosis prior to the AD/ACLF stage and correlates with development of infection and one-year mortality (33). Here, CD14 is linked to Alzheimer disease.